Home / Market News / $PATH
benzinga Corporate Catalyst Impact 55/100 ● negative

UBS Maintains Neutral on UiPath, Lowers Price Target to $14

Sep 25, 2026, 4:04 PM UTC · Primary ticker $PATH

UBS analyst Radi Sultan maintained a Neutral rating on UiPath (PATH) but lowered the price target from $15 to $14. This indicates a slightly more cautious outlook from the analyst, which could put minor downward pressure on the stock.

UBS analyst Radi Sultan reiterated a Neutral rating on UiPath (PATH) but reduced the price target from $15 to $14. This adjustment signals a slightly diminished valuation expectation from the analyst, likely due to updated financial models or market conditions specific to the software sector. For traders, this could translate into minor short-term selling pressure as the lower price target suggests less upside potential. While not a strong sell signal, it removes some bullish sentiment and highlights a cautious stance on the stock's immediate future, potentially impacting investor confidence.

$PATH negative Price target lowered by analyst
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.